Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

A parameter-free, solid-angle based, nearest-neighbor algorithm.

van Meel JA, Filion L, Valeriani C, Frenkel D.

J Chem Phys. 2012 Jun 21;136(23):234107. doi: 10.1063/1.4729313.

PMID:
22779581
2.

Design principles for broad-spectrum protein-crystal nucleants with nanoscale pits.

van Meel JA, Sear RP, Frenkel D.

Phys Rev Lett. 2010 Nov 12;105(20):205501. Epub 2010 Nov 8.

PMID:
21231245
3.

Numerical and theoretical study of a monodisperse hard-sphere glass former.

Charbonneau P, Ikeda A, van Meel JA, Miyazaki K.

Phys Rev E Stat Nonlin Soft Matter Phys. 2010 Apr;81(4 Pt 1):040501. Epub 2010 Apr 14.

PMID:
20481668
4.

Hard-sphere crystallization gets rarer with increasing dimension.

van Meel JA, Charbonneau B, Fortini A, Charbonneau P.

Phys Rev E Stat Nonlin Soft Matter Phys. 2009 Dec;80(6 Pt 1):061110. Epub 2009 Dec 8.

PMID:
20365121
5.

Lyapunov instability of rough hard-disk fluids.

van Meel JA, Posch HA.

Phys Rev E Stat Nonlin Soft Matter Phys. 2009 Jul;80(1 Pt 2):016206. Epub 2009 Jul 9.

PMID:
19658791
6.

Geometrical frustration: a study of four-dimensional hard spheres.

van Meel JA, Frenkel D, Charbonneau P.

Phys Rev E Stat Nonlin Soft Matter Phys. 2009 Mar;79(3 Pt 1):030201. Epub 2009 Mar 3.

PMID:
19391883
7.

Two-step vapor-crystal nucleation close below triple point.

van Meel JA, Page AJ, Sear RP, Frenkel D.

J Chem Phys. 2008 Nov 28;129(20):204505. doi: 10.1063/1.3026364.

PMID:
19045871
8.

Caenorhabditis elegans as model system for rapid toxicity assessment of pharmaceutical compounds.

Dengg M, van Meel JC.

J Pharmacol Toxicol Methods. 2004 Nov-Dec;50(3):209-14.

PMID:
15519907
9.

Inhibition of epidermal growth factor receptor activity by two pyrimidopyrimidine derivatives.

Solca FF, Baum A, Langkopf E, Dahmann G, Heider KH, Himmelsbach F, van Meel JC.

J Pharmacol Exp Ther. 2004 Nov;311(2):502-9. Epub 2004 Jun 15.

PMID:
15199094
10.

The small molecule Hesperadin reveals a role for Aurora B in correcting kinetochore-microtubule attachment and in maintaining the spindle assembly checkpoint.

Hauf S, Cole RW, LaTerra S, Zimmer C, Schnapp G, Walter R, Heckel A, van Meel J, Rieder CL, Peters JM.

J Cell Biol. 2003 Apr 28;161(2):281-94. Epub 2003 Apr 21.

11.

Hypotensive effects of the angiotensin II antagonist telmisartan in conscious chronically-instrumented transgenic rats.

van Meel JC, Redemann N, Haigh RM.

Arzneimittelforschung. 1996 Aug;46(8):755-9.

PMID:
9125273
12.

Low concentrations of UD-CG 212 enhance myocyte contractility by an increase in calcium responsiveness in the presence of inorganic phosphate.

van Meel JC, Redemann N, Diederen W, Haigh RM.

Naunyn Schmiedebergs Arch Pharmacol. 1995 Jun;351(6):644-50.

PMID:
7675124
13.

Effects of pimobendan and its metabolite on myofibrillar calcium responsiveness and ATPase activity in the presence of inorganic phosphate.

van Meel JC, Entzeroth M, Redemann N, Haigh RM.

Arzneimittelforschung. 1995 Feb;45(2):136-41.

PMID:
7710434
14.

Endothelium-dependent, nitric oxide-mediated inhibition of angiotensin II-induced contractions in rabbit aorta.

Zhang J, Van Meel JC, Pfaffendorf M, Zhang J, Van Zwieten PA.

Eur J Pharmacol. 1994 Sep 12;262(3):247-53.

PMID:
7813589
15.

Different types of angiotensin II receptor antagonism induced by BIBS 222 in the rat portal vein and rabbit aorta; the influence of receptor reserve.

Zhang JS, Van Meel JC, Pfaffendorf M, Van Zwieten PA.

J Pharmacol Exp Ther. 1994 May;269(2):509-14.

PMID:
8182519
16.

Inhibitory effect of dithiothreitol on angiotensin II-induced contractions mediated by AT1-receptors in rat portal vein and rabbit aorta.

Zhang JS, van Meel JC, Pfaffendorf M, van Zwieten PA.

Naunyn Schmiedebergs Arch Pharmacol. 1994 May;349(5):538-42.

PMID:
8065468
17.

Calcium dependency of the AT1-receptor mediated effects in the rat portal vein: influence of calcium antagonists.

Zhang JS, Van Meel JC, Pfaffendorf M, Zhang J, Van Zwieten PA.

Naunyn Schmiedebergs Arch Pharmacol. 1994 Apr;349(4):437-42.

PMID:
8058116
18.

6-Substituted benzimidazoles as new nonpeptide angiotensin II receptor antagonists: synthesis, biological activity, and structure-activity relationships.

Ries UJ, Mihm G, Narr B, Hasselbach KM, Wittneben H, Entzeroth M, van Meel JC, Wienen W, Hauel NH.

J Med Chem. 1993 Dec 10;36(25):4040-51.

PMID:
8258826
19.

Unexpected contractile response from the G-protein activator mastoparan in cardiac myocytes.

Van Meel JC, Haigh RM.

Eur J Pharmacol. 1993 Nov 15;247(3):357-8.

PMID:
8307108
20.

Pharmacological characterization of the novel nonpeptide angiotensin II receptor antagonist, BIBR 277.

Wienen W, Hauel N, Van Meel JC, Narr B, Ries U, Entzeroth M.

Br J Pharmacol. 1993 Sep;110(1):245-52.

21.
22.

The novel 5-HT4 receptor antagonist DAU 6285 antagonizes 5-hydroxytryptamine-induced tachycardia in pigs.

Van Meel JC, Diederen W, Haigh R, Wienen W, Pairet M, Turconi M, Doods HN.

Eur J Pharmacol. 1993 Mar 23;233(2-3):295-7.

PMID:
8467876
23.

Angiotensin II receptor antagonists.

van Meel JC, Entzeroth M, Hauel N, Narr B, Ries U, Wienen W.

Arzneimittelforschung. 1993 Feb;43(2A):242-6. Review.

PMID:
8498971
24.

Characterization of the angiotensin II-receptor subtype in the longitudinal smooth muscle of the rat portal vein.

Zhang JS, Van Meel JC, Pfaffendorf M, Van Zwieten PA.

Naunyn Schmiedebergs Arch Pharmacol. 1993 Feb;347(2):220-4.

PMID:
8474539
25.

Cholera toxin but not pertussis toxin inhibits angiotensin II-enhanced contractions in the rat portal vein.

Zhang J, Van Meel JC, Pfaffendorf M, Van Zwieten PA.

Eur J Pharmacol. 1993 Jan 5;230(1):95-7.

PMID:
8381358
26.

Characterization of BIBS 39 and BIBS 222: two new nonpeptide angiotensin II receptor antagonists.

Zhang J, Entzeroth M, Wienen W, Van Meel JC.

Eur J Pharmacol. 1992 Jul 21;218(1):35-41.

PMID:
1397034
27.
28.

The function of self-touchings, posture shifts, and motor discharges in children from 3 to 6 years of age.

Rögels PL, Roelen E, Van Meel JM.

Percept Mot Skills. 1990 Jun;70(3 Pt 2):1169-78.

PMID:
2399093
29.

Pimobendan increases calcium sensitivity of skinned human papillary muscle fibers.

Scheld HH, Fritsche R, Schlepper M, van Meel JC.

J Clin Pharmacol. 1989 Apr;29(4):360-6.

PMID:
2723124
30.

Pimobendan increases survival of cardiomyopathic hamsters.

van Meel JC, Mauz AB, Wienen W, Diederen W.

J Cardiovasc Pharmacol. 1989 Mar;13(3):508-9.

PMID:
2471899
31.

Hemodynamic profile of the cardiotonic agent pimobendan.

van Meel JC, Diederen W.

J Cardiovasc Pharmacol. 1989;14 Suppl 2:S1-6.

PMID:
2478784
32.

Increase in calcium sensitivity of cardiac myofibrils contributes to the cardiotonic action of sulmazole.

van Meel JC, Zimmermann R, Diederen W, Erdman E, Mrwa U.

Biochem Pharmacol. 1988 Jan 15;37(2):213-20.

PMID:
2829914
33.

Effects of some cardiotonic agents on contractility of skinned fibers from mammalian heart.

van Meel JC.

Arzneimittelforschung. 1987 Jun;37(6):679-82.

PMID:
3663265
34.

Comparison of some new positive inotropic agents in guinea pigs.

van Meel JC.

Pharmacology. 1985;31(1):1-10.

PMID:
3161096
35.

Differential effect of calcium entry blockers on alpha 1-adrenoceptor-mediated vasoconstriction in vivo.

Timmermans PB, Mathy MJ, Wilffert B, Kalkman HO, Thoolen MJ, de Jonge A, van Meel JC, van Zwieten PA.

Naunyn Schmiedebergs Arch Pharmacol. 1983 Dec;324(4):239-45.

PMID:
6141529
36.
37.

Differential inhibition of alpha 2-adrenoceptor-mediated pressor responses by (+)- and (-)-verapamil in pithed rats.

Van Meel JC, Qian JQ, Timmermans PB, Van Zwieten PA.

J Pharm Pharmacol. 1983 Aug;35(8):500-4.

PMID:
6137534
38.

Effect of adrenalectomy and demedullation of the adrenals on vasopressor responses to stimulation of postjunctional alpha 2-adrenoceptors.

Van Meel JC, Qian J, Wilffert B, De Jonge A, Timmermans PB, Van Zwieten PA.

Eur J Pharmacol. 1983 Jul 22;91(2-3):171-9.

PMID:
6311576
39.

alpha 1- and alpha 2-adrenoceptor stimulation in the isolated perfused hindquarters of the rat: an in vitro model.

van Meel JC, Timmermans PB, van Zwieten PA.

J Cardiovasc Pharmacol. 1983 Jul-Aug;5(4):580-5.

PMID:
6193354
40.

Pharmacology of calcium entry blockers: interaction with vascular alpha-adrenoceptors.

van Zwieten PA, van Meel JC, Timmermans PB.

Hypertension. 1983 Jul-Aug;5(4 Pt 2):II8-17. Review.

PMID:
6134673
41.

Calcium antagonists and alpha-receptors.

Timmermans PB, van Meel JC, van Zwieten PA.

Eur Heart J. 1983 May;4 Suppl C:11-7. Review. No abstract available.

PMID:
6311552
42.

Effect of captopril on sympathetic neurotransmission in pithed normotensive rats.

De Jonge A, Knape JT, Van Meel JC, Kalkman HO, Wilffert B, Thoolen MJ, Van Brummelen P, Timmermans PB, Van Zwieten PA.

Eur J Pharmacol. 1983 Mar 25;88(2-3):231-40.

PMID:
6303808
43.
44.

Functional interaction between calcium antagonists and the vasoconstriction induced by the stimulation of postsynaptic alpha 2-adrenoceptors.

van Zwieten PA, van Meel JC, Timmermans PB.

Circ Res. 1983 Feb;52(2 Pt 2):I77-80. No abstract available.

PMID:
6299607
45.

Hemodynamic characterization of pinacidil in rats. Comparison with hydralazine.

Thoolen MJ, Van Meel JC, Wilffert B, Timmermans PB, van Zwieten PA.

Pharmacology. 1983;27(5):245-54.

PMID:
6318232
46.

Hypotensive activity of tetrandrine in rats. Investigation into its mode of action.

Qian JQ, Thoolen MJ, van Meel JC, Timmermans PB, van Zwieten PA.

Pharmacology. 1983;26(4):187-97.

PMID:
6302716
47.

Influence of nifedipine on functional responses in vivo initiated at alpha 2-adrenoceptors.

Timmermans PB, de Jonge A, van Meel JC, Mathy MJ, van Zwieten PA.

J Cardiovasc Pharmacol. 1983 Jan-Feb;5(1):1-11.

PMID:
6186842
48.

Postsynaptic alpha 1- and alpha 2-adrenoceptor blocking properties of (dihydro)quinidine and (dihydro)quinine.

de Zoeten K, van Meel JC, van Kemenade JE, Batink HD, Timmermans PB, van Zwieten PA.

Arzneimittelforschung. 1983;33(5):694-8.

PMID:
6135431
49.

The inhibitory effect of newer calcium antagonists (nimodipine and PY-108-068) on vasoconstriction in vivo mediated by postsynaptic alpha 2-adrenoceptors.

Van Meel JC, Wilffert B, De Zoeten K, Timmermans PB, Van Zwieten PA.

Arch Int Pharmacodyn Ther. 1982 Dec;260(2):206-17.

PMID:
6299220
50.

Effect of converting enzyme inhibition and angiotensin receptor blockade on the vasoconstriction mediated by alpha 1-and alpha 2-adrenoceptor stimulation in pithed normotensive rats.

de Jonge A, Knape JT, van Meel JC, Kalkman HO, Wilffert B, Thoolen MJ, Timmermanns PB, van Zwieten PA.

Naunyn Schmiedebergs Arch Pharmacol. 1982 Dec;321(4):309-13. No abstract available.

PMID:
6188064

Supplemental Content

Loading ...
Support Center